The weekly litigation news digest is live. Subscribe now

IP Verse

Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement - EP3167888

The patent EP3167888 was granted to Alexion Pharmaceuticals on May 1, 2024. The application was filed on Mar 15, 2007 under application number EP16195355A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3167888

ALEXION PHARMACEUTICALS
Application Number
EP16195355A
Filing Date
Mar 15, 2007
Status
Granted And Under Opposition
Mar 29, 2024
Publication Date
May 1, 2024
External Links
Slate, Register, Google Patents

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_674/2025Jul 22, 2025Samsung Bioepis NLGeneric
UPC_CFI_51/2025Jan 23, 2025Samsung Bioepis NLGeneric
UPC_CFI_40/2025Jan 22, 2025Samsung Bioepis NLGeneric
APP_3053/2025Jan 21, 2025AmgenGeneric
APP_60271/2024Nov 8, 2024Name NOT Displayed FOR Gdpr Reasons Represented BY Jochen Hohfeld, Redacted Natural Person NameGeneric
UPC_CFI_642/2024Oct 31, 2024Amgen Switzerland Vilniaus FilialasRevocation
APP_43687/2024Jul 29, 2024Amgen Technology Ireland UnlimitedGeneric
APP_43786/2024Jul 26, 2024Samsung Bioepis NLGeneric
UPC_COA_405/2024Jul 11, 2024Alexion PharmaceuticalsAppeal
UPC_COA_402/2024Jul 11, 2024Alexion PharmaceuticalsAppeal

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SALUTE HC ILAC PAZARLAMAJan 31, 2025GRUNECKER PATENTADMISSIBLE
AMGEN TECHNOLOGY IRELAND UNLIMITEDOct 28, 2024DORRIESADMISSIBLE
AMGEN TECHNOLOGY IRELAND UNLIMITEDOct 28, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE
SAMSUNG BIOEPISMay 2, 2024SIMMONS & SIMMONS MUNICHADMISSIBLE

Patent Citations (58) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0120694
DESCRIPTIONEP0194276
DESCRIPTIONEP0239400
DESCRIPTIONEP0404097
DESCRIPTIONUS2003129187
DESCRIPTIONUS2003202972
DESCRIPTIONUS2004091490
DESCRIPTIONUS2005158316
DESCRIPTIONUS2005226870
DESCRIPTIONUS2005238646
DESCRIPTIONUS4816397
DESCRIPTIONUS4816567
DESCRIPTIONUS4946778
DESCRIPTIONUS5225539
DESCRIPTIONUS5260203
DESCRIPTIONUS5565332
DESCRIPTIONUS5660825
DESCRIPTIONUS5693762
DESCRIPTIONUS5789208
DESCRIPTIONUS6057131
DESCRIPTIONUS6100443
DESCRIPTIONUS6103889
DESCRIPTIONUS6180370
DESCRIPTIONUS6331415
DESCRIPTIONUS6335163
DESCRIPTIONUS6355245
DESCRIPTIONUS6407213
DESCRIPTIONUS6534058
DESCRIPTIONUS6548640
DESCRIPTIONWO03106644
DESCRIPTIONWO2004009618
DESCRIPTIONWO2004066957
DESCRIPTIONWO2004091658
DESCRIPTIONWO2005074607
DESCRIPTIONWO8601533
DESCRIPTIONWO9210205
DESCRIPTIONWO9311161
DESCRIPTIONWO9520401
EXAMINATIONUS2005271660
EXAMINATIONUS6355245
EXAMINATIONWO2005074607
OPPOSITIONUS2003232972
OPPOSITIONUS2005191298
OPPOSITIONUS6355245
OPPOSITIONWO2004050017
OPPOSITIONWO2004108158
OPPOSITIONWO2005007809
OPPOSITIONWO2005074607
OPPOSITIONWO9711971
OTHEREP1720571
OTHEREP1755674
OTHEREP1988882
OTHEREP2061810
OTHEREP2359834
OTHEREP2380907
OTHERUS2005271660
OTHERWO2007092772
SEARCHUS2005191298

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents